Mathys Sophie, von Ah Ueli, Lacroix Christophe, Staub Ernö, Mini Raffaella, Cereghetti Tania, Meile Leo
Laboratory of Food Biotechnology, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology (ETH), Zurich, Switzerland.
BMC Biotechnol. 2007 Sep 12;7:55. doi: 10.1186/1472-6750-7-55.
Bacteriocin-producing lactic acid bacteria are commonly used as natural protective cultures. Among them, strains of the genus Pediococcus are particularly interesting for their ability to produce pediocin, a broad spectrum antimicrobial peptide with a strong antagonistic activity against the food-borne pathogen Listeria monocytogenes. Furthermore, there is increasing interest in isolating new bacteriocin-producing strains of human intestinal origin that could be developed for probiotic effects and inhibition of pathogenic bacteria in the gut. In this work, we typed a new strain, co-isolated from baby faeces together with a Bifidobacterium thermophilum strain, and characterized its proteinaceous compound with strong antilisterial activity.
The newly isolated strain UVA1 was identified as a Pediococcus acidilactici by carbohydrate fermentation profile, growth at 50 degrees C and 16S rDNA sequencing. The partially purified bacteriocin was heat resistant up to 100 degrees C, active over a wide range of pH (2 to 9) and susceptible to proteolytic enzymes. The molecular weight, estimated by SDS-PAGE, was similar to that of pediocin AcH/PA-1 (4.5 kDa). P. acidilactici UVA1 harboured a 9.5-kb plasmid that could be cured easily, which resulted in the loss of the antimicrobial activity. Southern hybridization using the DIG-labelled pedA-probe established that the bacteriocin gene was plasmid-borne as for all pediocin described so far. Nucleotide sequence of the whole operon (3.5 kb) showed almost 100 % similarity to the pediocin AcH/PA-1 operon. The mRNA transcript for pedA could be detected in P. acidilactici UVA1 but not in the cured derivative, confirming the expression of the pedA-gene in UVA1. Using a new real-time PCR assay, eleven out of seventeen human faecal samples tested were found to contain pedA-DNA.
We identified and characterised the first pediocin produced by a human intestinal Pediococcus acidilactici isolate and successfully developed a new real-time PCR assay to show the large distribution of pedA-containing strains in baby faecal samples.
产细菌素的乳酸菌通常用作天然保护培养物。其中,片球菌属的菌株因其能够产生片球菌素而特别引人关注,片球菌素是一种广谱抗菌肽,对食源性病原体单核细胞增生李斯特菌具有强大的拮抗活性。此外,人们越来越有兴趣分离新的源自人类肠道的产细菌素菌株,这些菌株可用于开发益生菌效应并抑制肠道中的病原菌。在这项工作中,我们对一株与嗜热双歧杆菌菌株一起从婴儿粪便中共同分离出的新菌株进行了分型,并对其具有强大抗李斯特菌活性的蛋白质化合物进行了表征。
通过碳水化合物发酵谱、50℃生长情况和16S rDNA测序,新分离的菌株UVA1被鉴定为嗜酸片球菌。部分纯化的细菌素在高达100℃时耐热,在广泛的pH范围(2至9)内具有活性,并且对蛋白水解酶敏感。通过SDS-PAGE估计的分子量与片球菌素AcH/PA-1(4.5 kDa)相似。嗜酸片球菌UVA1携带一个9.5 kb的质粒,该质粒易于消除,这导致抗菌活性丧失。使用DIG标记的pedA探针进行的Southern杂交表明,细菌素基因如迄今为止描述的所有片球菌素一样是质粒携带的。整个操纵子(3.5 kb)的核苷酸序列与片球菌素AcH/PA-1操纵子显示出几乎100%的相似性。在嗜酸片球菌UVA1中可以检测到pedA的mRNA转录本,但在消除质粒的衍生物中未检测到,这证实了pedA基因在UVA1中的表达。使用一种新的实时PCR检测方法,在测试的17份人类粪便样本中,有11份被发现含有pedA-DNA。
我们鉴定并表征了第一株由人类肠道嗜酸片球菌分离株产生的片球菌素,并成功开发了一种新的实时PCR检测方法,以显示含pedA菌株在婴儿粪便样本中的广泛分布。